Serum Cotinine Level as Predictor of Lung Cancer Risk
Authors:
- 1 June 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 15 (6) , 1184-1188
Abstract
Background: No prospective studies are available on serum cotinine level as a marker of lung cancer risk.Methods: We analyzed serum cotinine level among 1,741 individuals enrolled since the 1970s in a prospective study of Norwegian volunteers who developed lung cancer during the follow-up and 1,741 matched controls free from lung cancer. Serum cotinine was measured with a competitive immunoassay. Regression dilution was corrected for based on repeated measures on samples from 747 subjects.Results: Mean serum cotinine level was higher in cases than in controls. Compared with subjects with a cotinine level of ≤5 ng/mL, the odds ratio of lung cancer was increasing linearly, reaching 55.1 (95% confidence interval, 35.7-85.0) among individuals with a serum cotinine level of >378 ng/mL. There was no clear suggestion of a plateau in risk at high exposure levels. Odds ratios were very similar in men and women. We found no association between serum cotinine level (range, 0.1-9.9 ng/mL) and lung cancer risk among self-reported nonsmokers and long-term quitters (79 cases and 350 controls).Discussion: The association between tobacco smoking and lung cancer risk might be stronger than is estimated from questionnaire-based studies. Serum cotinine level is a predictor of risk of lung cancer among smokers. The reported plateau in risk at high doses is likely due mainly to artifacts. There is no difference between men and women in the carcinogenicity of tobacco smoking. (Cancer Epidemiol Biomarkers Prev 2006;15(6):1184–8)Keywords
This publication has 32 references indexed in Scilit:
- Accuracy of self-reported smoking status among participants in a chemoprevention trialPreventive Medicine, 2004
- Clinical considerations in study designs that use cotinine as a biomarkerBiomarkers, 2003
- Validation of self reported smoking by serum cotinine measurement in a community-based studyJournal of Epidemiology and Community Health, 2002
- Passive smoking by self report and serum cotinine and the prevalence of respiratory and coronary heart disease in the Scottish heart health study.Journal of Epidemiology and Community Health, 1995
- Is Serum Cotinine a Better Measure of Cigarette-Smoking Than Self-Report?Preventive Medicine, 1995
- Floating absolute risk: An alternative to relative risk in survival and case‐control analysis avoiding an arbitrary reference groupStatistics in Medicine, 1991
- Cotinine validation of self-reported smoking in commercially run community surveysJournal of Chronic Diseases, 1987
- Inhaling and lung cancer: an anomaly explained.BMJ, 1983
- Cigarette smoking: Carboxyhemoglobin, plasma nicotine, cotinine and thiocyanate vs self-reported smoking data and cardiovascular diseaseJournal of Chronic Diseases, 1983
- Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers.Journal of Epidemiology and Community Health, 1978